We are lowering our Bristol Myers price target despite an earnings beat
Bristol Myers Squibb ‘s earnings beat and rosy outlook Thursday did not resolve lingering issues for the stock.…
Bristol Myers Squibb (BMY) earnings Q1 2025
FILE PHOTO: The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec.…
Eli Lilly sues compounded Mounjaro, Zepbound providers
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec.…